Kaya, B. Et Al. 2025. Design, Synthesis, Biological Evaluation, and Molecular Docking Studies of Novel 1,3,4-Thiadiazole Derivatives Targeting Both Aldose Reductase and α-Glucosidase for Diabetes Mellitus. ACS Omega , vol.10, no.18 , 18812-18828.

Kaya, B., ACAR ÇEVİK, U., Necip, A., Duran, H. E., ÇİFTCİ, B., IŞIK, M., ... SOYER, P.(2025). Design, Synthesis, Biological Evaluation, and Molecular Docking Studies of Novel 1,3,4-Thiadiazole Derivatives Targeting Both Aldose Reductase and α-Glucosidase for Diabetes Mellitus. ACS Omega , vol.10, no.18, 18812-18828.

Kaya, BETÜL Et Al. "Design, Synthesis, Biological Evaluation, and Molecular Docking Studies of Novel 1,3,4-Thiadiazole Derivatives Targeting Both Aldose Reductase and α-Glucosidase for Diabetes Mellitus," ACS Omega , vol.10, no.18, 18812-18828, 2025

Kaya, BETÜL Et Al. "Design, Synthesis, Biological Evaluation, and Molecular Docking Studies of Novel 1,3,4-Thiadiazole Derivatives Targeting Both Aldose Reductase and α-Glucosidase for Diabetes Mellitus." ACS Omega , vol.10, no.18, pp.18812-18828, 2025

Kaya, B. Et Al. (2025) . "Design, Synthesis, Biological Evaluation, and Molecular Docking Studies of Novel 1,3,4-Thiadiazole Derivatives Targeting Both Aldose Reductase and α-Glucosidase for Diabetes Mellitus." ACS Omega , vol.10, no.18, pp.18812-18828.

@article{article, author={BETÜL KAYA Et Al. }, title={Design, Synthesis, Biological Evaluation, and Molecular Docking Studies of Novel 1,3,4-Thiadiazole Derivatives Targeting Both Aldose Reductase and α-Glucosidase for Diabetes Mellitus}, journal={ACS Omega}, year=2025, pages={18812-18828} }